Turkey is supporting six coronavirus vaccine projects, according to a senior health official.
“Currently, six vaccine projects are supported under TUSEB” and transaction processes for two more vaccine projects are underway, Erhan Akdogan, director of Turkish Health Institutes (TUSEB), told the agency. Anadolu.
The projects are carried out at six Turkish universities, including Erciyes, Hacettepe, Yildiz Teknik, Marmara, Ataturk and Akdeniz.
Among those projects, the Erciyes University vaccine candidate is in phase 2 testing, Akdogan said.
“Research continues at the university […] Scientific processes are underway for the development of a vaccine. We hope the vaccine will be released soon, ”he said.
A little more time is needed to unveil the preliminary results of the Erciyes University project, he added.
“Scientists and TUSEB as well as TUBITAK [Scientific and Technological Research Council of Turkey] provided the necessary research and development support very quickly and continues to do so, ”he added.
TUSEB began supporting science projects for vaccine development immediately after the first case of the coronavirus was reported in Turkey, Akdogan said.
Nasal spray candidate vaccine
While the vaccine candidate developed at Erciyes University is inactive, Akdogan said there are many types of vaccine studies underway in Turkey, including one in the form of a nasal spray.
“This is also a new technology in the world,” he said, adding that his research and development process was continuing.
“Human trials have not yet started for this vaccine candidate. This is a different vaccine developed by a private organization, ”he added.
The product will be released once the scientific studies on national vaccines are completed, Akdogan said, adding that when the phase 3 trial is completed and it has obtained the necessary approvals from the Turkish Medicines and Medical Devices Agency, it will go into production and a general vaccination will be carried out.
“The production will take place in Turkey,” he added.
Akdogan also said that research teams from TUSEB-backed COVID-19 vaccine projects met for a workshop in the capital Ankara on March 21-22.
Pointing out that scientists have gained significant experience in local vaccine research, Akdogan said they have come together to collaborate and share their experience as well as for interaction between scientists.